These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 8751173

  • 1. Felbamate overdose: a case report and discussion of a new antiepileptic drug.
    Nagel TR, Schunk JE.
    Pediatr Emerg Care; 1995 Dec; 11(6):369-71. PubMed ID: 8751173
    [Abstract] [Full Text] [Related]

  • 2. Felbamate pharmacology and use in epilepsy.
    Burdette DE, Sackellares JC.
    Clin Neuropharmacol; 1994 Oct; 17(5):389-402. PubMed ID: 9316688
    [Abstract] [Full Text] [Related]

  • 3. [Felbamate: perspectives for new antiepileptic treatment].
    Pérez-Miranda J, Aguirre J, Parrilla JL, Pérez Miranda M.
    Rev Neurol; 1995 Oct; 23(124):1220-5. PubMed ID: 8556622
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).
    Felbamate Study Group in Lennox-Gastaut Syndrome.
    N Engl J Med; 1993 Jan 07; 328(1):29-33. PubMed ID: 8347179
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Felbamate: clinical and molecular aspects of a unique antiepileptic drug.
    Brown WM, Aiken SP.
    Crit Rev Neurobiol; 1998 Jan 07; 12(3):205-22. PubMed ID: 9847055
    [Abstract] [Full Text] [Related]

  • 7. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
    Palmer KJ, McTavish D.
    Drugs; 1993 Jun 07; 45(6):1041-1065. PubMed ID: 7691493
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Is there any future for felbamate treatment?
    Borowicz KK, Piskorska B, Kimber-Trojnar Z, Małek R, Sobieszek G, Czuczwar SJ.
    Pol J Pharmacol; 2004 Jun 07; 56(3):289-94. PubMed ID: 15215558
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Felbamate: a new antiepileptic drug.
    Wagner ML.
    Am J Hosp Pharm; 1994 Jul 01; 51(13):1657-66. PubMed ID: 7942890
    [Abstract] [Full Text] [Related]

  • 12. Reversible downbeat nystagmus and ataxia in felbamate intoxication.
    Hwang TL, Still CN, Jones JE.
    Neurology; 1995 Apr 01; 45(4):846. PubMed ID: 7723985
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuropsychiatric side effects related to treatment with felbamate.
    McConnell H, Snyder PJ, Duffy JD, Weilburg J, Valeriano J, Brillman J, Cress K, Cavalier J.
    J Neuropsychiatry Clin Neurosci; 1996 Apr 01; 8(3):341-6. PubMed ID: 8854308
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Changes of the EEG paroxysmal pattern during felbamate therapy in Lennox-Gastaut syndrome: a case report.
    Marciani MG, Spanedda F, Placidi F, Bassetti MA, Romigi A, Mattia D.
    Int J Neurosci; 1998 Sep 01; 95(3-4):247-53. PubMed ID: 9777442
    [Abstract] [Full Text] [Related]

  • 17. Felbamate.
    Bourgeois BF.
    Semin Pediatr Neurol; 1997 Mar 01; 4(1):3-8. PubMed ID: 9097361
    [Abstract] [Full Text] [Related]

  • 18. Felbamate: consensus of current clinical experience.
    Pellock JM, Faught E, Leppik IE, Shinnar S, Zupanc ML.
    Epilepsy Res; 2006 Oct 01; 71(2-3):89-101. PubMed ID: 16889941
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.